The recent public appearance of King Charles has highlighted public concerns regarding an unidentified spot in his eyes. Know more about the condition.

Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase ...